Status: Recruiting
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
The goal of this study is to evaluate Effectiveness and safety of Spartina® (Tirzepatide) in male or female participants with obesity and overweight. The main questions which are aimed to be answered: 1. Is Spartina® (Tirzepatide) effective in the treatment of obesity and overweight? 2. Is Spartina® (Tirzepatide) safe in the treatment of obesity and overweight? In this study, there is no comparison group. Participants receive Spartina® (Tirzepatide)
Participants needed: 175
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: CinnagenUpdated: Dec 16, 2025Locations: 14
Eligibility criteria
Male or female ≥18 years of age [+2]
Prior use of any GLP-1 agonist in the last 6 months [+4]